Rockville, MD, USA, Aug. 22, 2017 -- The Regulatory Affairs Professionals Society (RAPS) has revealed the names of the six outstanding senior regulatory professionals who will join the elite group of RAPS Fellows this year. They will be recognized during the opening plenary session of the RAPS Regulatory Convergence conference at the Gaylord National Resort and Convention Center at National Harbor on the Washington, DC, waterfront 9–12 September. The Convergence is the largest annual gathering of the global regulatory profession.
“To be selected as a RAPS Fellow is an honor reserved for senior regulatory professionals who have continuously advanced the profession and served as leaders throughout their careers,” said Fellows Selection Committee Chair Nancy Gertlar, president of Crossroads Consulting. “These six distinguished experts will serve as important resources for knowledge and guidance to RAPS and to the entire global regulatory community.”
|
||||||
The 2017 RAPS Fellows are:
- Kaia Agarwal, MSc, FRAPS, president, Regulatory Compass LLC
- Mark De Rosch, PhD, FRAPS, senior vice president, regulatory affairs, quality assurance, and CMC, Akebia Therapeutics
- Susan Hamann, MS, RAC, MT (ASCP), FRAPS, president, Hamann QR Consulting
- Joel Kent, RAC, FRAPS, manager, regulatory affairs, GE Healthcare
- Darin Oppenheimer, PhD, RAC, FRAPS, executive director, head, Drug Device Center of Excellence, Merck
- Joanne Palmisano, MD, FACP, FRAPS, vice president, regulatory affairs, Boehringer Ingelheim Pharmaceuticals Inc.
Reporters, bloggers and other members of the media who wish to cover all or part of the RAPS Regulatory Convergence should contact Zachary Brousseau, senior manager, communications, RAPS, at [email protected] or +1 301 770 2920, ext. 245. On-site registration also will be available for media with valid press credentials or a letter from an assigning editor.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with chapters and affiliates worldwide. www.RAPS.org
###
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/fda7a9d3-5c26-4e4d-a42c-19b4f1f9c534
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e893afd9-000a-4745-b8c3-b9874c5d25b4
Zachary Brousseau Regulatory Affairs Professionals Society (RAPS) 301 770 2920, ext. 245 [email protected]


Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 



